As of Feb 15
| +1.15 / +2.43%|
The 7 analysts offering 12-month price forecasts for Avanos Medical Inc have a median target of 57.00, with a high estimate of 68.00 and a low estimate of 36.00. The median estimate represents a +17.62% increase from the last price of 48.46.
The current consensus among 8 polled investment analysts is to Buy stock in Avanos Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.